Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

ALKS 55.98 -0.10 (-0.18%)
price chart
The Alkermes PLC (ALKS) Stock Rating Reaffirmed by Cantor Fitzgerald
Alkermes PLC (NASDAQ:ALKS)'s stock had its “neutral” rating reiterated by Cantor Fitzgerald in a research report issued to clients and investors on Wednesday.
Stock Returns: ARIAD Pharmaceuticals Inc (NASDAQ:ARIA) is Beating Alkermes ...  CML News
Elliot Ehrich Sells 11983 Shares of Alkermes PLC (ALKS) Stock  Community Financial News
Why Alkermes PLC Skyrocketed Today
Alkermes tested ALKS 5461 in patients with major depressive disorder who haven't been helped by other drugs. At the higher dose, ALKS 5461 improved symptoms of depression -- based on two different scales used by doctors -- compared with placebo.
Alkermes plc (ALKS) Announces Third ALKS 5461 Phase 3 Met Primary Endpoint ...  StreetInsider.com
Alkermes Jumps After Depression Drug Hits Goal in Late Trial  Bloomberg
Alkermes PLC: Sales Rise, Losses Fall, and the Pipeline Moves Forward
Alkermes (NASDAQ:ALKS), a biopharmaceutical company that specializes in extended-release drug delivery technology, reported third-quarter results on Nov. 2 and provided investors with an update on its pipeline.
Alkermes PLC (ALKS) CMO Elliot Ehrich Sells 11983 Shares
Alkermes PLC logo Alkermes PLC (NASDAQ:ALKS) CMO Elliot Ehrich sold 11,983 shares of the stock in a transaction that occurred on Tuesday, January 17th.
The Alkermes PLC (ALKS) SVP Sells $567652.65 in Stock  DailyQuint
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2015 and ...
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.
Alkermes Plc (ALKS) Richard F. Pops on Q4 2015 Results - Earnings Call ...  Seeking Alpha
Alkermes plc (ALKS) Moves Lower on Volume Spike for January 11
Alkermes plc (ALKS) traded on unusually high volume on Jan. 11, as the stock lost 6.65% to close at $54.60. On the day, Alkermes plc saw 1.97 million shares trade hands on 21,364 trades. Considering that the stock averages only a daily volume of 788 ...
Alkermes PLC (ALKS) Insider Shane Cooke Sells 550 Shares  The Cerbat Gem
Alkermes PLC (ALKS) SVP Mark Stejbach Sells 547 Shares  BBNS
Alkermes plc Reports Third Quarter 2016 Financial Results
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for the third quarter of 2016. “Our third quarter results demonstrate the value of our highly-diversified commercial portfolio, and were driven by the strong growth ...
Alkermes' (ALKS) CEO Richard Pops on Q3 2016 Results - Earnings Call ...  Seeking Alpha
Alkermes plc Reports Second Quarter 2016 Financial Results
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for the second quarter of 2016. “Our second quarter results demonstrate the power of our business model to efficiently capture operating leverage as our topline ...
Alkermes Plc (ALKS) Richard Pops on Q2 2016 Results - Earnings Call Transcript  Seeking Alpha
Alkermes (ALKS) Posts Narrower Q2 Loss, Ups 2016 Outlook  Zacks.com
Alkermes Plc (NASDAQ:ALKS) Heffx Trading Outlook
During the past 10 bars, there have been 5 white candles and 5 black candles. During the past 50 bars, there have been 27 white candles and 23 black candles for a net of 4 white candles.
Alkermes plc (ALKS) Moves Higher on Volume Spike for January 04
Alkermes plc (ALKS) traded on unusually high volume on Jan. 04, as the stock gained 6.77% to close at $59.90. On the day, Alkermes plc saw 1.18 million shares trade hands on 11,707 trades. Considering that the stock averages only a daily volume of ...
Alkermes PLC (ALKS) Director Paul J. Mitchell Sells 1500 Shares of Stock  Sports Perspectives
Alkermes PLC (ALKS) Stake Reduced by Canada Pension Plan Investment Board  The Cerbat Gem